Jounce Therapeutics (NASDAQ:JNCE – Get Rating) and Kymera Therapeutics (NASDAQ:KYMR – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, profitability, valuation and analyst recommendations. Institutional & Insider Ownership 80.7% of Jounce Therapeutics shares […]